SAFC Adapts to Changing Pharmaceuticals Market

Sigma Aldrich Fine Chemicals, of late the fastest growing division within the Sigma Aldrich group, says the business environment it operates in is changing significantly and rapidly and that it is adapting its business model accordingly.   A key dynamic is the shift by big pharmaceutical companies away from blockbuster pharmaceutical products toward more specialist drugs with smaller sales, says Frank Wicks, president of SAFC. Pharma companies stand to lose $55 billion in sales during the next five years as a slew of drugs go off patent. “The specter...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers